bupropion has been researched along with Acathisia, Drug-Induced in 6 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors reanalyzed data from the 17 placebo-controlled randomized controlled trials (N=8,027) of varenicline conducted by Pfizer, using complete intent-to-treat person-level longitudinal data to assess smoking abstinence and reports of suicidal thoughts and behavior, depression, aggression/agitation, and nausea and to compare effects in patients with (N=1,004) and without (N=7,023) psychiatric disorders." | 7.79 | Varenicline, smoking cessation, and neuropsychiatric adverse events. ( Gibbons, RD; Mann, JJ, 2013) |
| "The authors reanalyzed data from the 17 placebo-controlled randomized controlled trials (N=8,027) of varenicline conducted by Pfizer, using complete intent-to-treat person-level longitudinal data to assess smoking abstinence and reports of suicidal thoughts and behavior, depression, aggression/agitation, and nausea and to compare effects in patients with (N=1,004) and without (N=7,023) psychiatric disorders." | 3.79 | Varenicline, smoking cessation, and neuropsychiatric adverse events. ( Gibbons, RD; Mann, JJ, 2013) |
| "Bupropion was studied in four double-blind, placebo-controlled trials (N = 360) at dosages of 300-750 mg/day." | 2.65 | Methodologic approach to adverse events applied to bupropion clinical trials. ( Cato, AE; Cook, L; Heatherington, D; Starbuck, R, 1983) |
| "The incidence of a seizure was less than 1 per 1,000 at usual outpatient doses and less than 1 per 100 at usual inpatient doses." | 2.65 | Overview of clinically significant adverse reactions to bupropion. ( Cato, AE; Fleck, RJ; Harto-Truax, N; Manberg, PJ; Miller, LL; Sato, T; Stern, WC; Van Wyck Fleet, J, 1983) |
| "Despite the superior side effect profile of the newer antidepressants over the tricyclics and monoamine oxidase inhibitors, all newer antidepressants are associated with a wide array of side effects." | 1.31 | The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists. ( Dording, CM; Fava, M; Gordon, J; Kornbluh, R; Mischoulon, D; Nierenberg, AA; Petersen, TJ; Rosenbaum, JE, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibbons, RD | 1 |
| Mann, JJ | 1 |
| Dording, CM | 1 |
| Mischoulon, D | 1 |
| Petersen, TJ | 1 |
| Kornbluh, R | 1 |
| Gordon, J | 1 |
| Nierenberg, AA | 1 |
| Rosenbaum, JE | 1 |
| Fava, M | 1 |
| Menza, MA | 1 |
| Dobkin, RD | 1 |
| Marin, H | 1 |
| Cato, AE | 2 |
| Cook, L | 1 |
| Starbuck, R | 1 |
| Heatherington, D | 1 |
| Van Wyck Fleet, J | 1 |
| Manberg, PJ | 1 |
| Miller, LL | 1 |
| Harto-Truax, N | 1 |
| Sato, T | 1 |
| Fleck, RJ | 1 |
| Stern, WC | 1 |
| Stoll, AL | 1 |
| Mayer, PV | 1 |
| Kolbrener, M | 1 |
| Goldstein, E | 1 |
| Suplit, B | 1 |
| Lucier, J | 1 |
| Cohen, BM | 1 |
| Tohen, M | 1 |
3 trials available for bupropion and Acathisia, Drug-Induced
| Article | Year |
|---|---|
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsyc | 2007 |
Methodologic approach to adverse events applied to bupropion clinical trials.
Topics: Akathisia, Drug-Induced; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Diso | 1983 |
Overview of clinically significant adverse reactions to bupropion.
Topics: Adult; Aged; Akathisia, Drug-Induced; Ambulatory Care; Antidepressive Agents; Antidepressive Agents, | 1983 |
3 other studies available for bupropion and Acathisia, Drug-Induced
| Article | Year |
|---|---|
Varenicline, smoking cessation, and neuropsychiatric adverse events.
Topics: Adult; Aggression; Akathisia, Drug-Induced; Benzazepines; Bupropion; Depression; Female; Humans; Mal | 2013 |
The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists.
Topics: Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Bupropion; Critical Pathways; Dat | 2002 |
Antidepressant-associated mania: a controlled comparison with spontaneous mania.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Dis | 1994 |